Articolo in rivista, 2024, ENG, 10.1007/978-1-0716-3714-2_5
De Robertis, Mariangela; Signori, Emanuela
CNR - Istituto di Farmacologia Traslazionale; Università degli studi di Bari Aldo Moro
Recent progress in developing new vaccination strategies against cancer requires the production of complex and reliable animal models reflecting the complexity of the tumors with their microenvironment. Mice can be considered a good source due to low cost and ease of being genetically modified, inoculated with tumor cell lines or treated by chemicals to induce different cancers. Despite significant limitations in modeling human cancer complexity, preclinical trials conducted in mice can efficiently contribute to understand molecular mechanisms of cancer, to closely resemble and follow carcinogenesis steps impossible to study into humans, and to test new anticancer therapies. In this chapter, we generally describe the different mouse models developed for cancer vaccines' preclinical trials. A particular focus is dedicated to a chemically-induced colorectal cancer model in use in our laboratories.
Methods in molecular biology (Clifton N.J., Online) 2773 , pp. 51–58
AOM/DSS mouse model, Cancer vaccines, Chemically-induced tumors, Colorectal cancer, Mouse models
ID: 492302
Year: 2024
Type: Articolo in rivista
Creation: 2024-01-30 14:42:46.000
Last update: 2024-01-30 16:56:18.000
CNR authors
CNR institutes
External links
OAI-PMH: Dublin Core
OAI-PMH: Mods
OAI-PMH: RDF
DOI: 10.1007/978-1-0716-3714-2_5
URL: http://www.scopus.com/record/display.url?eid=2-s2.0-85182763706&origin=inward
External IDs
CNR OAI-PMH: oai:it.cnr:prodotti:492302
DOI: 10.1007/978-1-0716-3714-2_5
Scopus: 2-s2.0-85182763706